Navigation Links
Trial Therapy Improves Melanoma Survival
Date:8/19/2010

By Amanda Gardner
HealthDay Reporter

WEDNESDAY, Aug. 18 (HealthDay News) -- An experimental drug for metastatic melanoma prolonged median survival from 6.4 months to 10 months, which, although seemingly small, represents a significant extension of life for this normally intractable disease, a new study found.

And a subgroup of patients given the drug, known as ipilimumab, lived as long as six years, according to research published in the Aug. 19 issue of the New England Journal of Medicine.

This type of skin cancer has an average survival time of six to nine months.

"This is the first drug that's ever been shown in a randomized, controlled trial to offer a survival benefit for patients," said study lead author Dr. F. Stephen Hodi, director of the melanoma disease center at Dana Farber Cancer Institute in Boston.

The findings were first reported in June at the annual meeting of the American Society of Clinical Oncology in Chicago. The study was funded by Bristol-Myers Squibb and its biotechnology subsidiary Medarex, which makes ipilimumab.

Only two drugs have been approved by the U.S. Food and Drug Administration to treat melanoma that has spread beyond its original site: interleukin 2, or IL-2, and dacarbazine. IL-2 is a drug that affects the immune system while dacarbazine is a chemotherapy agent.

There have been no new FDA approvals of drugs for metastatic melanoma in more than a decade.

Ipilimumab is a human monoclonal antibody, which targets an antigen known as CTLA-4 that is found on the surface of T cells, which are blood cells that protect the body from infection.

CTLA-4 inhibits the immune system and "ipilimumab releases the brakes to the immune system," Hodi explained. That way, T cells are free to move throughout the body and attack the melanoma cells.

For this study, 676 patients with advanced melanoma were randomly chosen to receive either ipilimumab
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CRF announces featured clinical trials to be presented at TCT 2010
2. Clinical trials: Comprehension unaffected by simplified consent forms or payment
3. Clinical trials abroad: Making non-English language consent forms readable
4. Human clinical trial of NIH-developed dengue vaccine begins
5. CRF announces late breaking trials and first report investigations to be presented at TCT 2010
6. Drug trials funded by industry are more likely to publish favorable results
7. Clinical trials can be improved by managing the learning curve
8. Sickle cell treatment developed at LA BioMed enters Phase 3 clinical trial
9. Microbicide trial results a turning point for HIV prevention, says team testing same gel
10. Many False-Positive HIV Test Results for Those in AIDS Vaccine Trials
11. BioSTARTM device achieves 90 percent closure rate for atrial septal defect in children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... 2015 , ... On Saturday, May 30th, 2015, Best Drug Rehabilitation sponsored a ... Mendon, IL. The purpose behind this concert was to raise money for music education ... Drug Rehabilitation’s sponsorship of “Music with a Mission” helped with a portion of the ...
(Date:8/31/2015)... ... August 31, 2015 , ... "While working as an ... effectively deliver oxygen with a lower risk of failure," explained an inventor, from ... the Adam Device." , The Adam Device offers a quick, effective and predictable ...
(Date:8/31/2015)... ... August 31, 2015 , ... Westchester ... Grand Prairie, is teaming up with the Tarrant County chapter of Meals on ... on Wheels is the oldest and largest national organization that supports the more ...
(Date:8/31/2015)... ... August 31, 2015 , ... It’s a lot like coming home. Life-long ... of Geneva. During his first days on the job, he’s run into residents of ... and I like knowing that they’re living in such a wonderful place,” he said. ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Now here’s some ... advice to "make at least half your grains whole,” with the majority of Americans ... Oldways Whole Grains Council (WGC) released these findings and others from the ...
Breaking Medicine News(10 mins):Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3Health News:InventHelp® Client's Invents Medical Device to Restore Respiratory Function (BGF-905) 2Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 2Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 3Health News:Friendship Senior Options Welcomes New Executive Director for GreenFields of Geneva 2Health News:Most Americans Now Make Half Their Grains Whole 2Health News:Most Americans Now Make Half Their Grains Whole 3Health News:Most Americans Now Make Half Their Grains Whole 4Health News:Most Americans Now Make Half Their Grains Whole 5
... a one in eight lifetime risk that a woman will ... remains early detection. Now, Women & infants Hospital of Rhode ... level with the installation of the most advanced imaging technology ... the first and only facility in southeastern New England to ...
... effort to replace animal fat in hot dogs, sausages, hamburgers ... advance in solving the mystery of why hot dogs develop ... animal fat. A report on their study appears in ACS, ... M. Herrero and colleagues explain that some brands of sausage ...
... proven the continuing effectiveness of treating patients with ... acid in addition to adjuvant endocrine treatment including ... Austrian Breast & Colorectal Cancer Study Group (ABCSG-12), ... Cancer Symposium, held Dec. 6-10, 2011, confirmed and ...
... waves, could stop many victims of major head injury from ... Neurology has found. Scientists have been investigating ... now of keen interest to the U.S. military because head ... in Iraq and Afghanistan. Researchers at King,s College London ...
... 2011 A research team led by scientists at the Chinese ... how a bacterium, Helicobacter pylori , that causes more than ... stomach cancer has managed for eons to turn the acidic environment ... Writing in a Journal of Biological Chemistry "Paper ...
... Post-menopausal women with hormone receptor-positive metastatic breast cancer ... their lives, according to results of a study by ... the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. ... fulvestrant used in the SWOG S0226 trial extended the ...
Cached Medicine News:Health News:Hospital gives first tomosynthesis mammograms in region this week 2Health News:Zoledronic acid shows long-term benefit in survivorship for premenopausal ER-positive breast cancer 2Health News:Brain tsunamis' are clue to helping victims of major head injuries 2Health News:Brain tsunamis' are clue to helping victims of major head injuries 3Health News:Closing in on an ulcer- and cancer-causing bacterium 2Health News:Closing in on an ulcer- and cancer-causing bacterium 3Health News:Anti-estrogen combo better than single drug for hormone-sensitive breast cancer 2
(Date:8/31/2015)... FLINT, Mich. , Aug. 31, 2015  Diplomat Pharmacy, ... pharmacy, has announced that Phil Hagerman , Chairman & ... four upcoming investor conferences. Mr. Hagerman and ... 2015 Healthcare Conference in Boston on ... Mr. Hagerman and Mr. Whelan are also scheduled to participate ...
(Date:8/31/2015)... 2015 BioLight Life ... ("BioLight" or the "Company"), a firm that invests ... and cancer diagnostics, today announced that its cancer ... several new genetic markers with high potential to ... with bisphosphonate drugs and was able to repeat ...
(Date:8/31/2015)... , Aug. 31, 2015  Soligenix, Inc. ... biopharmaceutical company developing products that address unmet medical ... biodefense, announced today it has completed enrollment of ... Review Committee (DRC) earlier this year, into the ... a first-in-class innate defense regulator (IDR) and is ...
Breaking Medicine Technology:Diplomat to Participate in Upcoming Investor Conferences 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6
Control Plasma for Assays of Unfractionated Heparins (UH) using Anti-Xa Methodon STA© Analyzers....
... Normal and Abnormal ... Assays of vWF, D-dimer ... on STA© Analyzers. For ... vWF (#0518),STA© LIATEST© D-DI ...
CRP high sensitivity calibrator series...
Inquire...
Medicine Products: